Colin Green

Publikationer
Populärvetenskap och samverkan

Artiklar

Article: JOURNAL OF OCCUPATIONAL REHABILITATION. 2021;31(3):613-626

Exploring the Factors that Influence Workforce Participation for People with Multiple Sclerosis: A Discrete Choice Experiment.

Goodwin E; Hawton A; Whitty JA; Green C
Article: NEUROMODULATION. 2021;24(6):1033-1041

Resource Use and Cost of Subcutaneous Nerve Stimulation Versus Optimized Medical Management in Patients With Failed Back Surgery Syndrome: An Analysis of the SubQStim Study.

Green C; Eldabe SS; Taylor RS; Zahra M; Eggington S
Article: PILOT AND FEASIBILITY STUDIES. 2021;7(1):2

Balance Right in Multiple Sclerosis (BRiMS): a feasibility randomised controlled trial of a falls prevention programme.

Gunn H; Stevens KN; Creanor S; Andrade J; Paul L; Miller L; Green C; Ewings P; Barton A; Berrow M; Vickery J; Marshall B; Zajicek J; Freeman JA
Article: BMJ OPEN. 2020;10(12):e043331

Randomised controlled trial of tailored support to increase physical activity and reduce smoking in smokers not immediately ready to quit: protocol for the Trial of physical Activity-assisted Reduction of Smoking (TARS) Study.

Taylor A; Thompson TP; Ussher M; Aveyard P; Murray RL; Harris T; Creanor S; Green C; Streeter AJ; Chynoweth J; Ingram W; Greaves CJ; Hancocks H; Snowsill T; Callaghan L; Price L; Horrell J; King J; Gude A; George M; Wahlich C; Hamilton L; Cheema K; Campbell S; Preece D
Article: VALUE IN HEALTH. 2020;23(2):242-250

What Difference Does It Make? A Comparison of Health State Preferences Elicited From the General Population and From People With Multiple Sclerosis.

Goodwin E; Green C; Hawton A
Article: EUROPEAN JOURNAL OF HEALTH ECONOMICS. 2019;20(9):1335-1347

Health state utility values (QALY weights) for Huntington's disease: an analysis of data from the European Huntington's Disease Network (EHDN).

Hawton A; Green C; Goodwin E; Harrower T
Article: ALZHEIMERS & DEMENTIA. 2019;15(10):1309-1321

Assessing cost-effectiveness of early intervention in Alzheimer's disease: An open-source modeling framework

Green C; Handels R; Gustavsson A; Wimo A; Winblad B; Skoldunger A; Jonsson L
Article: HEALTH AND QUALITY OF LIFE OUTCOMES. 2019;17(1):136

Using the Fatigue Severity Scale to inform healthcare decision-making in multiple sclerosis: mapping to three quality-adjusted life-year measures (EQ-5D-3L, SF-6D, MSIS-8D).

Goodwin E; Hawton A; Green C
Article: NEUROMODULATION. 2019;22(5):519-528

A Randomized Controlled Trial of Subcutaneous Nerve Stimulation for Back Pain Due to Failed Back Surgery Syndrome: The SubQStim Study.

Eldabe SS; Taylor RS; Goossens S; Bouche B; Gültuna I; Green C; Tinsley J; Luyet P-P; Buchser E
Article: HEALTH TECHNOLOGY ASSESSMENT. 2019;23(27):1-166

A self-management programme to reduce falls and improve safe mobility in people with secondary progressive MS: the BRiMS feasibility RCT

Gunn H; Andrade J; Paul L; Miller L; Creanor S; Stevens K; Green C; Ewings P; Barton A; Berrow M; Vickery J; Marshall B; Zajicek J; Freeman J
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2019;26(3):262-272

The effects and costs of home-based rehabilitation for heart failure with reduced ejection fraction: The REACH-HF multicentre randomized controlled trial.

Dalal HM; Taylor RS; Jolly K; Davis RC; Doherty P; Miles J; van Lingen R; Warren FC; Green C; Wingham J; Greaves C; Sadler S; Hillsdon M; Abraham C; Britten N; Frost J; Singh S; Hayward C; Eyre V; Paul K; Lang CC; Smith K
Article: VALUE IN HEALTH. 2018;21(11):1338-1345

Health State Values Derived from People with Multiple Sclerosis for a Condition-Specific Preference-Based Measure: Multiple Sclerosis Impact Scale-Eight Dimensions-Patient Version (MSIS-8D-P).

Goodwin E; Green C; Hawton A
Article: BMJ OPEN. 2018;8(6):e023123

Health trainer-led motivational intervention plus usual care for people under community supervision compared with usual care alone: a study protocol for a parallel-group pilot randomised controlled trial (STRENGTHEN).

Thompson TP; Callaghan L; Hazeldine E; Quinn C; Walker S; Byng R; Wallace G; Creanor S; Green C; Hawton A; Annison J; Sinclair J; Senior J; Taylor AH
Article: TRIALS. 2018;19(1):228

A community-based physical activity intervention to prevent mobility-related disability for retired older people (REtirement in ACTion (REACT)): study protocol for a randomised controlled trial.

Stathi A; Withall J; Greaves CJ; Thompson JL; Taylor G; Medina-Lara A; Green C; Bilzon J; Gray S; Johansen-Berg H; Sexton CE; Western MJ; de Koning JL; Bollen JC; Moorlock SJ; Demnitz N; Seager P; Guralnik JM; Jack Rejeski W; Fox KR
Article: BMJ OPEN. 2018;8(4):e019649

A randomised controlled trial of a facilitated home-based rehabilitation intervention in patients with heart failure with preserved ejection fraction and their caregivers: the REACH-HFpEF Pilot Study.

Lang CC; Smith K; Wingham J; Eyre V; Greaves CJ; Warren FC; Green C; Jolly K; Davis RC; Doherty PJ; Miles J; Britten N; Abraham C; Van Lingen R; Singh SJ; Paul K; Hillsdon M; Sadler S; Hayward C; Dalal HM; Taylor RS; REACH-HF investigators,
Article: LANCET CHILD & ADOLESCENT HEALTH. 2018;2(1):35-45

Effectiveness of the Healthy Lifestyles Programme (HeLP) to prevent obesity in UK primary-school children: a cluster randomised controlled trial.

Lloyd J; Creanor S; Logan S; Green C; Dean SG; Hillsdon M; Abraham C; Tomlinson R; Pearson V; Taylor RS; Ryan E; Price L; Streeter A; Wyatt K
Article: PILOT AND FEASIBILITY STUDIES. 2018;4:26

Balance Right in Multiple Sclerosis (BRiMS): a guided self-management programme to reduce falls and improve quality of life, balance and mobility in people with secondary progressive multiple sclerosis: a protocol for a feasibility randomised controlled trial.

Gunn H; Andrade J; Paul L; Miller L; Creanor S; Green C; Marsden J; Ewings P; Berrow M; Vickery J; Barton A; Marshall B; Zajicek J; Freeman JA
Article: MEDICAL DECISION MAKING. 2017;37(6):703-714

"Naming and Framing": The Impact of Labeling on Health State Values for Multiple Sclerosis.

Green C; Goodwin E; Hawton A
Article: BMC PUBLIC HEALTH. 2017;17(1):291

Trial baseline characteristics of a cluster randomised controlled trial of a school-located obesity prevention programme; the Healthy Lifestyles Programme (HeLP) trial.

Lloyd J; Creanor S; Price L; Abraham C; Dean S; Green C; Hillsdon M; Pearson V; Taylor RS; Tomlinson R; Logan S; Hurst A; Ryan E; Daurge W; Wyatt K
Article: ALZHEIMERS & DEMENTIA. 2017;13(3):312-321

Current issues and future research priorities for health economic modelling across the full continuum of Alzheimer's disease

Gustavsson A; Green C; Jones RW; Foerstl H; Simsek D; de Vulpillieres FDR; Luthman S; Adlard N; Bhattacharyya S; Wimo A
Article: TRIALS. 2016;17(1):599

Detailed statistical analysis plan for a cluster randomised controlled trial of the Healthy Lifestyles Programme (HeLP), a novel school-based intervention to prevent obesity in school children.

Creanor S; Lloyd J; Hillsdon M; Dean S; Green C; Taylor RS; Ryan E; Wyatt K; HeLP Trial Management Group
Article: BMJ OPEN. 2016;6(10):e012853

Rehabilitation Enablement in Chronic Heart Failure-a facilitated self-care rehabilitation intervention in patients with heart failure with preserved ejection fraction (REACH-HFpEF) and their caregivers: rationale and protocol for a single-centre pilot randomised controlled trial.

Eyre V; Lang CC; Smith K; Jolly K; Davis R; Hayward C; Wingham J; Abraham C; Green C; Warren FC; Britten N; Greaves CJ; Doherty P; Austin J; Van Lingen R; Singh S; Buckingham S; Paul K; Taylor RS; Dalal HM; REACH-HF investigators
Article: EUROPEAN JOURNAL OF HEALTH ECONOMICS. 2016;17(7):875-884

Multiple sclerosis: relapses, resource use, and costs.

Hawton AJ; Green C
Article: ALZHEIMERS & DEMENTIA. 2016;12(7):776-785

Predicting the progression of Alzheimer's disease dementia: A multidomain health policy model.

Green C; Zhang S
Article: VALUE IN HEALTH. 2016;19(4):460-468

Health Utilities for Multiple Sclerosis.

Hawton A; Green C
Article: BMC NEUROLOGY. 2016;16:62

Standing up in multiple sclerosis (SUMS): protocol for a multi-centre randomised controlled trial evaluating the clinical and cost effectiveness of a home-based self-management standing frame programme in people with progressive multiple sclerosis.

Freeman JA; Hendrie W; Creanor S; Jarrett L; Barton A; Green C; Marsden J; Rogers E; Zajicek J
Article: BRITISH JOURNAL OF GENERAL PRACTICE. 2016;66(644):e214-e218

Telephone triage systems in UK general practice: analysis of consultation duration during the index day in a pragmatic randomised controlled trial.

Holt TA; Fletcher E; Warren F; Richards S; Salisbury C; Calitri R; Green C; Taylor R; Richards DA; Varley A; Campbell J
Article: NICOTINE & TOBACCO RESEARCH. 2016;18(3):289-297

An Exploratory Analysis of the Smoking and Physical Activity Outcomes From a Pilot Randomized Controlled Trial of an Exercise Assisted Reduction to Stop Smoking Intervention in Disadvantaged Groups.

Thompson TP; Greaves CJ; Ayres R; Aveyard P; Warren FC; Byng R; Taylor RS; Campbell JL; Ussher M; Green C; Michie S; West R; Taylor A
Article: HEALTH TECHNOLOGY ASSESSMENT. 2016;20(14):1-192

Clinical effectiveness and cost-effectiveness of collaborative care for depression in UK primary care (CADET): a cluster randomised controlled trial.

Richards DA; Bower P; Chew-Graham C; Gask L; Lovell K; Cape J; Pilling S; Araya R; Kessler D; Barkham M; Bland JM; Gilbody S; Green C; Lewis G; Manning C; Kontopantelis E; Hill JJ; Hughes-Morley A; Russell A
Article: BMJ OPEN. 2015;5(12):e009994

Clinical effectiveness and cost-effectiveness of the Rehabilitation Enablement in Chronic Heart Failure (REACH-HF) facilitated self-care rehabilitation intervention in heart failure patients and caregivers: rationale and protocol for a multicentre randomised controlled trial.

Taylor RS; Hayward C; Eyre V; Austin J; Davies R; Doherty P; Jolly K; Wingham J; Van Lingen R; Abraham C; Green C; Warren FC; Britten N; Greaves CJ; Singh S; Buckingham S; Paul K; Dalal H; REACH-HF Investigators
Article: VALUE IN HEALTH. 2015;18(8):1016-1024

A Quality-Adjusted Life-Year Measure for Multiple Sclerosis: Developing a Patient-Reported Health State Classification System for a Multiple Sclerosis-Specific Preference-Based Measure.

Goodwin E; Green C
Article: HEALTH AND QUALITY OF LIFE OUTCOMES. 2015;13:87

Meaningful health outcomes for paediatric neurodisability: Stakeholder prioritisation and appropriateness of patient reported outcome measures.

Morris C; Janssens A; Shilling V; Allard A; Fellowes A; Tomlinson R; Williams J; Thompson Coon J; Rogers M; Beresford B; Green C; Jenkinson C; Tennant A; Logan S
Article: BMC FAMILY PRACTICE. 2015;16:47

Implementing telephone triage in general practice: a process evaluation of a cluster randomised controlled trial.

Murdoch J; Varley A; Fletcher E; Britten N; Price L; Calitri R; Green C; Lattimer V; Richards SH; Richards DA; Salisbury C; Taylor RS; Campbell JL
Article: INTERNATIONAL JOURNAL OF BEHAVIORAL NUTRITION AND PHYSICAL ACTIVITY. 2015;12:1

Waste the waist: a pilot randomised controlled trial of a primary care based intervention to support lifestyle change in people with high cardiovascular risk.

Greaves C; Gillison F; Stathi A; Bennett P; Reddy P; Dunbar J; Perry R; Messom D; Chandler R; Francis M; Davis M; Green C; Evans P; Taylor G
Article: LANCET. 2014;384(9957):1859-1868

Telephone triage for management of same-day consultation requests in general practice (the ESTEEM trial): a cluster-randomised controlled trial and cost-consequence analysis.

Campbell JL; Fletcher E; Britten N; Green C; Holt TA; Lattimer V; Richards DA; Richards SH; Salisbury C; Calitri R; Bowyer V; Chaplin K; Kandiyali R; Murdoch J; Roscoe J; Varley A; Warren FC; Taylor RS
Article: PLOS ONE. 2014;9(8):e104225

Cost-effectiveness of collaborative care for depression in UK primary care: economic evaluation of a randomised controlled trial (CADET).

Green C; Richards DA; Hill JJ; Gask L; Lovell K; Chew-Graham C; Bower P; Cape J; Pilling S; Araya R; Kessler D; Bland JM; Gilbody S; Lewis G; Manning C; Hughes-Morley A; Barkham M
Article: PHYSIOTHERAPY. 2013;99(4):352-357

Exercise and self-management for people with chronic knee, hip or lower back pain: a cluster randomised controlled trial of clinical and cost-effectiveness. Study protocol.

Walsh N; Cramp F; Palmer S; Pollock J; Hampson L; Gooberman-Hill R; Green C; Jones L; Phillips S; Johnson L; Hurley M
Article: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2013;84(10):1092-1099

A pragmatic parallel arm multi-centre randomised controlled trial to assess the effectiveness and cost-effectiveness of a group-based fatigue management programme (FACETS) for people with multiple sclerosis.

Thomas S; Thomas PW; Kersten P; Jones R; Green C; Nock A; Slingsby V; Smith AD; Baker R; Galvin KT; Hillier C
Article: BMJ-BRITISH MEDICAL JOURNAL. 2013;347:f4913

Clinical effectiveness of collaborative care for depression in UK primary care (CADET): cluster randomised controlled trial.

Richards DA; Hill JJ; Gask L; Lovell K; Chew-Graham C; Bower P; Cape J; Pilling S; Araya R; Kessler D; Bland JM; Green C; Gilbody S; Lewis G; Manning C; Hughes-Morley A; Barkham M
Article: TRIALS. 2013;14:95

The Healthy Lifestyles Programme (HeLP), a novel school-based intervention to prevent obesity in school children: study protocol for a randomised controlled trial.

Wyatt KM; Lloyd JJ; Abraham C; Creanor S; Dean S; Densham E; Daurge W; Green C; Hillsdon M; Pearson V; Taylor RS; Tomlinson R; Logan S
Article: SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY. 2013;48(2):337-344

Estimating the costs of ongoing care for adolescents with attention-deficit hyperactivity disorder.

Telford C; Green C; Logan S; Langley K; Thapar A; Ford T
Article: TRIALS. 2013;14:4

The effectiveness and cost-effectiveness of telephone triage of patients requesting same day consultations in general practice: study protocol for a cluster randomised controlled trial comparing nurse-led and GP-led management systems (ESTEEM).

Campbell JL; Britten N; Green C; Holt TA; Lattimer V; Richards SH; Richards DA; Salisbury C; Taylor RS; Fletcher E
Article: IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING. 2013;60(1):164-168

Machine learning-based method for personalized and cost-effective detection of Alzheimer's disease.

Escudero J; Ifeachor E; Zajicek JP; Green C; Shearer J; Pearson S; Alzheimer's Disease Neuroimaging Initiative
Article: VALUE IN HEALTH. 2012;15(8):1084-1091

Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.

Hawton A; Green C; Telford C; Zajicek J; Wright D
Article: ALZHEIMERS & DEMENTIA. 2012;8(5):445-452

Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit.

Naylor MD; Karlawish JH; Arnold SE; Khachaturian AS; Khachaturian ZS; Lee VM-Y; Baumgart M; Banerjee S; Beck C; Blennow K; Brookmeyer R; Brunden KR; Buckwalter KC; Comer M; Covinsky K; Feinberg LF; Frisoni G; Green C; Guimaraes RM; Gwyther LP; Hefti FF; Hutton M; Kawas C; Kent DM; Kuller L; Langa KM; Mahley RW; Maslow K; Masters CL; Meier DE; Neumann PJ; Paul SM; Petersen RC; Sager MA; Sano M; Schenk D; Soares H; Sperling RA; Stahl SM; van Deerlin V; Stern Y; Weir D; Wolk DA; Trojanowski JQ
Article: BMC PUBLIC HEALTH. 2012;12:624

Physical activity and health related quality of life.

Anokye NK; Trueman P; Green C; Pavey TG; Taylor RS
Article: MULTIPLE SCLEROSIS JOURNAL. 2012;18(6):853-861

The use of multiple sclerosis condition-specific measures to inform health policy decision-making: mapping from the MSWS-12 to the EQ-5D.

Hawton A; Green C; Telford CJ; Wright DE; Zajicek JP
Article: BMC PUBLIC HEALTH. 2011;11:954

The cost-effectiveness of exercise referral schemes.

Anokye NK; Trueman P; Green C; Pavey TG; Hillsdon M; Taylor RS
Article: HEALTH TECHNOLOGY ASSESSMENT. 2011;15(44):i-254

The clinical effectiveness and cost-effectiveness of exercise referral schemes: a systematic review and economic evaluation.

Pavey TG; Anokye N; Taylor AH; Trueman P; Moxham T; Fox KR; Hillsdon M; Green C; Campbell JL; Foster C; Mutrie N; Searle J; Taylor RS
Article: BMC PUBLIC HEALTH. 2011;11:218

An evaluation of the effectiveness of a community mentoring service for socially isolated older people: a controlled trial.

Dickens AP; Richards SH; Hawton A; Taylor RS; Greaves CJ; Green C; Edwards R; Campbell JL
Article: QUALITY OF LIFE RESEARCH. 2011;20(1):57-67

The impact of social isolation on the health status and health-related quality of life of older people.

Hawton A; Green C; Dickens AP; Richards SH; Taylor RS; Edwards R; Greaves CJ; Campbell JL
Article: VALUE IN HEALTH. 2010;13(1):55-60

Cost-effectiveness of sorafenib for second-line treatment of advanced renal cell carcinoma.

Hoyle M; Green C; Thompson-Coon J; Liu Z; Welch K; Moxham T; Stein K
Article: VALUE IN HEALTH. 2010;13(1):61-68

Cost-effectiveness of temsirolimus for first line treatment of advanced renal cell carcinoma.

Hoyle M; Green C; Thompson-Coon J; Liu Z; Welch K; Moxham T; Stein K
Article: BMC HEALTH SERVICES RESEARCH. 2009;9:188

Collaborative Depression Trial (CADET): multi-centre randomised controlled trial of collaborative care for depression--study protocol.

Richards DA; Hughes-Morley A; Hayes RA; Araya R; Barkham M; Bland JM; Bower P; Cape J; Chew-Graham CA; Gask L; Gilbody S; Green C; Kessler D; Lewis G; Lovell K; Manning C; Pilling S
Article: SOCIAL SCIENCE & MEDICINE. 2009;68(12):2247-2255

Investigating public preferences on 'severity of health' as a relevant condition for setting healthcare priorities.

Green C
Article: INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE. 2009;25(1):1-5

Assessing the impact of England's National Health Service R&D Health Technology Assessment program using the "payback" approach.

Raftery J; Hanney S; Green C; Buxton M
Article: INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE. 2006;22(1):90-100

Evaluation of the cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in the United Kingdom.

Green C; Dinnes J; Takeda AL; Cuthbertson BH
Article: PHARMACOECONOMICS. 2005;23(12):1271-1282

Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease.

Green C; Picot J; Loveman E; Takeda A; Kirby J; Clegg A
Article: BRITISH JOURNAL OF DERMATOLOGY. 2005;152(1):130-141

Topical corticosteroids for atopic eczema: clinical and cost effectiveness of once-daily vs. more frequent use.

Green C; Colquitt JL; Kirby J; Davidson P
Article: QUALITY OF LIFE RESEARCH. 2003;12(5):565-574

Patients' health-related quality-of-life and health state values for motor neurone disease/amyotrophic lateral sclerosis.

Green C; Kiebert G; Murphy C; Mitchell JD; O'Brien M; Burrell A; Leigh PN
Visa fler

Alla övriga publikationer

Review: INTERNATIONAL JOURNAL OF OLDER PEOPLE NURSING. 2020;15(4):e12325

The experiences of hospital staff who provide care for people living with dementia: A systematic review and synthesis of qualitative studies

Gwernan-Jones R; Abbott R; Lourida I; Rogers M; Green C; Ball S; Hemsley A; Cheeseman D; Clare L; Moore DA; Hussey C; Coxon G; Llewellyn DJ; Naldrett T; Thompson Coon J
Meeting abstract: JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH. 2020;74:A46.2-A47

IMPROVING THE EXPERIENCE OF CARE FOR PEOPLE WITH DEMENTIA IN HOSPITAL: DEVELOPING THE DEMENTIA CARE POINTERS FOR SERVICE CHANGE

Coon JT; Abbott R; Lourida I; Gwernan-Jones R; Rogers M; Cheeseman D; Moore D; Green C; Ball S; Clare L; Llewellyn D; Hemsley A; Burton J; Lawrence S; Rogers M; Hussey C; Coxon G; Naldrett T
Review: BMC GERIATRICS. 2020;20(1):131

Activity interventions to improve the experience of care in hospital for people living with dementia: a systematic review.

Lourida I; Gwernan-Jones R; Abbott R; Rogers M; Green C; Ball S; Hemsley A; Cheeseman D; Clare L; Moore D; Hussey C; Coxon G; Llewellyn DJ; Naldrett T; Thompson Coon J
Meeting abstract: AGE AND AGEING. 2019;48:ii24-ii26

IMPROVING THE EXPERIENCE OF CARE FOR PEOPLE WITH DEMENTIA IN HOSPITAL: SYNTHESIS OF QUALITATIVE AND QUANTITATIVE EVIDENCE

Thompson-Coon J; Jones RG; Lourida I; Abbott R; Rogers M; Llewellyn D; Green C; Richards D; Ball S; Hemsley A; Moore D; Lang I; Clare L; Owens C
Review: INTERNATIONAL PSYCHOGERIATRICS. 2018;30(11):1593-1605

Where are we at with model-based economic evaluations of interventions for dementia? a systematic review and quality assessment.

Nguyen K-H; Comans TA; Green C
Meeting abstract: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2018;89(10):A20.3-A20

EQ-5D IN THE ASSESSMENT OF RELAPSE RECOVERY IN MS

Wynford-Thomas R; Harding K; Hawton A; Hirst C; Tallantyre E; Green C; Robertson N
Meeting abstract: VALUE IN HEALTH. 2018;21:S326

TIME-DEPENDENT VARIATION OF PRO SCORES IN CHRONIC CONDITIONS: A SCOPING REVIEW

Davey A; Green C; Porter I; Valderas JM
Meeting abstract: VALUE IN HEALTH. 2018;21:S14

EXPLORING TIME-DEPENDENT VARIATION OF PATIENT-REPORTED OUTCOME SCORES ACROSS DIFFERENT TIME-POINTS FOR PATIENTS WITH MULTIPLE CONDITIONS: A MIXED METHODS LONGITUDINAL STUDY

Davey A; Porter I; Green C; Valderas JM
Meeting abstract: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2018;89:A49.1-A49

QUALITY-ADJUSTED LIFE-YEARS (QALYS) AND HUNTINGTON'S DISEASE

Green C; Goodwin E; Hawton A
Meeting abstract: HEART. 2018;104:A43.2-A44

REHABILITATION ENABLEMENT IN CHRONIC HEART FAILURE (REACH-HF) A MULTICENTRE RANDOMISED CONTROLLED TRIAL OF FACILITATED SELF-CARE REHABILITATION INTERVENTION IN HEART FAILURE WITH REDUCED EJECTION FRACTION

Dalal H; Jolly K; Davis R; Doherty P; Austin J; van Lingen R; Warren F; Green C; Wingham J; Britten N; Greaves C; Abraham C; Singh S; Paul K; Lang C; Smith K; Eyre V; Hayward C; Taylor R
Meeting abstract: VALUE IN HEALTH. 2017;20(9):A746

APPROACHES TO MODELLING THE COST-EFFECTIVENESS OF INTERVENTIONS FOR HEART FAILURE: A SYSTEMATIC REVIEW

Sadler S; Watson L; Crathorne L; Green C
Meeting abstract: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2016;87(12):e1.23-e1

UK PATIENT PREFERENCE FOR CHARACTERISTICS OF DMTS IN MS

Bottomley C; Padania S; Lloyd A; Gary B; Green C; Adlard N
Meeting abstract: VALUE IN HEALTH. 2016;19(7):A377

CURRENT ISSUES AND FUTURE RESEARCH PRIORITIES FOR HEALTH ECONOMIC MODELLING OF AT RISK POPULATION FOR ALZHEIMER'S DISEASE/DEMENTIA

Gustavsson A; Green C; Jones RW; Simsek D; de Vulpillieres DRF; Adlard N; Bhattacharyya S; Wimo A; ForstlFoerstl H; Luthman S
Review: APPLIED HEALTH ECONOMICS AND HEALTH POLICY. 2016;14(2):161-183

A Systematic Review of the Literature on the Development of Condition-Specific Preference-Based Measures of Health.

Goodwin E; Green C
Review: VALUE IN HEALTH. 2015;18(2):334-345

A systematic review of generic multidimensional patient-reported outcome measures for children, part II: evaluation of psychometric performance of English-language versions in a general population.

Janssens A; Rogers M; Thompson Coon J; Allen K; Green C; Jenkinson C; Tennant A; Logan S; Morris C
Review: VALUE IN HEALTH. 2015;18(2):315-333

A systematic review of generic multidimensional patient-reported outcome measures for children, part I: descriptive characteristics.

Janssens A; Thompson Coon J; Rogers M; Allen K; Green C; Jenkinson C; Tennant A; Logan S; Morris C
Meeting abstract: VALUE IN HEALTH. 2014;17(7):A563

Modeling Disease Progression In Alzheimer's Dementia To Inform HTA (CEA).

Green C; Zhang S
Review: DRUGS & AGING. 2012;29(1):31-43

Health state values for use in the economic evaluation of treatments for Alzheimer's disease.

Shearer J; Green C; Ritchie CW; Zajicek JP
Review: VALUE IN HEALTH. 2011;14(5):621-630

Model-based economic evaluation in Alzheimer's disease: a review of the methods available to model Alzheimer's disease progression.

Green C; Shearer J; Ritchie CW; Zajicek JP
Review: APPLIED HEALTH ECONOMICS AND HEALTH POLICY. 2011;9(4):243-258

The use of decision-analytic models in Parkinson's disease: a systematic review and critical appraisal.

Shearer J; Green C; Counsell CE; Zajicek JP
Review: HEALTH TECHNOLOGY ASSESSMENT. 2010;14(2):1-iv

Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation.

Thompson Coon J; Hoyle M; Green C; Liu Z; Welch K; Moxham T; Stein K
Review: PHARMACOECONOMICS. 2007;25(9):735-750

Modelling disease progression in Alzheimer's disease: a review of modelling methods used for cost-effectiveness analysis.

Green C
Visa fler

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI